Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Fortive Corporation reported strong second-quarter results marked by consistent growth across its two main segments: Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS).</li><li>The company achieved core revenue growth of 6.7%, adjusted EBITDA growth of 12%, and adjusted earnings per share (EPS) growth of 28%, representing the fourth consecutive quarter of double-digit adjusted EPS expansion.</li><li>Total revenue reached nearly $1.1 billion, reflecting 8% year-over-year growth on a reported basis.</li></ul>

Fortive Corporation reported strong second-quarter results marked by consistent growth across its two main segments: Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS).The company achieved core revenue growth of 6.7%, adjusted EBITDA growth of 12%, and adjusted earnings per share (EPS) growth of 28%, representing the fourth consecutive quarter of double-digit adjusted EPS expansion.Total revenue reached nearly $1.1 billion, reflecting 8% year-over-year growth on a reported basis.

Fortive Corporation Generates Over $1 Billion In Cash Flow — What Comes Next?

Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

<ul>
  <li>Fortive's core strength lies in its portfolio of market-leading brands in niche industrial technology sectors, underpinned by the <a href="https://smartkarma.com/entities/fortive-corp">Fortive </a>Business System (FBS), a culture of continuous improvement inherited from Danaher that drives operational excellence and margin expansion.</li>
  <li>The company is strategically pivoting towards higher-growth, recurring revenue streams by expanding its software and healthcare technology offerings, a move intended to reduce cyclicality and improve revenue quality.</li>
  <li>Despite a solid operational foundation, <a href="https://smartkarma.com/entities/fortive-corp">Fortive </a>faces headwinds from potential margin pressure due to product mix and tariffs, cautious demand in certain end-markets like hospital capital, and a challenging historical growth track record across key financial metrics.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  Fortive's core strength lies in its portfolio of market-leading brands in niche industrial technology sectors, underpinned by the Fortive Business System (FBS), a culture of continuous improvement inherited from Danaher that drives operational excellence and margin expansion.
  The company is strategically pivoting towards higher-growth, recurring revenue streams by expanding its software and healthcare technology offerings, a move intended to reduce cyclicality and improve revenue quality.
  Despite a solid operational foundation, Fortive faces headwinds from potential margin pressure due to product mix and tariffs, cautious demand in certain end-markets like hospital capital, and a challenging historical growth track record across key financial metrics.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

US-EU Index & Corporate Actions Analyst, ORTEX

Harry Kalfas

US-EU Index & Corporate Actions Analyst

Global Financial Data and Analytics Platform

ORTEX

ORTEX is a global financial data and analytics platform providing real-time securities lending and short interest data, index rebalance data, holdings and insider transactions, trading signals, corporate actions and news,  stock machine learning and factor scores and other analytics. The majority of the data are downloadable and accessible through APIs.

Index Rebalance

<ul>
<li>
<a href="https://www.smartkarma.com/entities/fortive-corp" target="_blank" data-smartkarma-citation="entities:26508:1" rel="noopener">Fortive (FTV US)</a> to spin off its Precision Technologies segment, under the name "Ralliant".</li>
<li>Key details on dates, transaction rationale, structure and estimated market capitalisation of the spin-off company.</li>
<li>Significant index implications ahead, across US and Global indexes, on an intra-quarter basis.</li>
</ul>



Fortive (FTV US) to spin off its Precision Technologies segment, under the name "Ralliant".
Key details on dates, transaction rationale, structure and estimated market capitalisation of the spin-off company.
Significant index implications ahead, across US and Global indexes, on an intra-quarter basis.


Fortive Spins Off Ralliant: Big US and Global Index Implications Ahead

<ul><li>Fortive Corporation reported a solid start to fiscal year 2026, delivering year-over-year core revenue growth of just over 5% and adjusted EBITDA growth of 13%, alongside a notable 25% increase in adjusted earnings per share.</li><li>The company attributed part of its revenue growth to an approximate 150 basis point benefit from additional year-over-year selling days in the quarter.</li><li>The results were driven by performance across its two main segments—Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS)—each exhibiting strength through price and volume growth, supported by solid demand in North America and a sequential improvement in Europe.</li></ul>

Fortive Corporation reported a solid start to fiscal year 2026, delivering year-over-year core revenue growth of just over 5% and adjusted EBITDA growth of 13%, alongside a notable 25% increase in adjusted earnings per share.The company attributed part of its revenue growth to an approximate 150 basis point benefit from additional year-over-year selling days in the quarter.The results were driven by performance across its two main segments—Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS)—each exhibiting strength through price and volume growth, supported by solid demand in North America and a sequential improvement in Europe.

Fortive Faces Tariff Pressure As Hospital Capital Demand Stays Cautious!

<ul><li>Fortive Corporation has delivered a promising performance in its fourth quarter and full-year 2025 financial results.</li><li>Examining the company's recent earnings call offers a well-rounded understanding of Fortive's strategic trajectory, financial health, and market dynamics.</li><li>Fortive's fourth-quarter performance featured robust execution across its portfolio, chiefly propelled by its Fortive Accelerated strategy.</li></ul>

Fortive Corporation has delivered a promising performance in its fourth quarter and full-year 2025 financial results.Examining the company's recent earnings call offers a well-rounded understanding of Fortive's strategic trajectory, financial health, and market dynamics.Fortive's fourth-quarter performance featured robust execution across its portfolio, chiefly propelled by its Fortive Accelerated strategy.

Fortive: Fluke’s Technology Leadership Is Unlocking New High-Value Growth Opportunities!

United States

Fortive Corporation operates as a diversified industrial growth company. The Company focuses on professional instrumentation, automation, sensing, and transportation technologies. Fortive serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Fortive (FTV US)

Fortive Corporation Generates Over $1 Billion In Cash Flow — What Comes Next?

Fortive Corporation reported strong second-quarter results marked by consistent growth across its two main segments: Intelligent Operating...

Baptista Research

Primer: Fortive (FTV US) - Aug 2026

Fortive's core strength lies in its portfolio of market-leading brands in niche industrial technology sectors, underpinned by the Fortive...

αSK Primers

Fortive Spins Off Ralliant: Big US and Global Index Implications Ahead

Fortive (FTV) spins off Ralliant (RAL) to sharpen focus; deal triggers major US and global index reshuffling with intra-quarter implications expected.

Harry Kalfas

Fortive Faces Tariff Pressure As Hospital Capital Demand Stays Cautious!

Fortive Corporation reported a solid start to fiscal year 2026, delivering year-over-year core revenue growth of just over 5% and adjusted EBITDA...

Baptista Research

Fortive: Fluke’s Technology Leadership Is Unlocking New High-Value Growth Opportunities!

Fortive Corporation has delivered a promising performance in its fourth quarter and full-year 2025 financial results. Examining the company's...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)